News Releases
Dialogue to Release Financial Results for the Second Quarter of 2023 on August 14, 2023
Dialogue to Release Financial Results for the Second Quarter of 2023 on August 14, 2023
Canada NewsWire
MONTREAL, July 31, 2023
MONTREAL, July 31, 2023 /CNW/ – Dialogue Health Technologies Inc. (TSX: CARE) (“Dialogue” or the “Company”), Canada’s pr…
Dialogue to Release Financial Results for the Second Quarter of 2023 on August 14, 2023
Canada NewsWire
MONTREAL, July 31, 2023
MONTREAL, July 31, 2023 /CNW/ – Dialogue Health Technologies Inc. (TSX: CARE) (“Dialogue” or the “Company”), Canada’s premier virtual healthcare and wellness platform, will release financial results for the second quarter of 2023 on Monday, August 14, 2023, at 4:30 p.m. ET.
As a result of the announcement on Wednesday, July 26, 2023, that Dialogue has entered into a definitive agreement to be acquired by Sun Life, the Company will not host a live session with analysts.
Incorporated in 2016, Dialogue is Canada’s premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. Through our team of health professionals, we serve employers and organizations who have an interest in the health and well-being of their employees, members and their families. Our Integrated Health Platform™ is a one-stop healthcare hub that centralizes all of our programs in a single, user-friendly application, providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet. Dialogue is the first virtual care provider to receive the Accreditation Canada Primer award, a third-party validation of safety and high-level quality of care.
SOURCE Dialogue Health Technologies Inc.
tsx
tsx-care
dialogue-health-technologies-inc
dialogue health technologies inc
press-release
nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) Announces an Expansion of its YMI Validation Project
Calgary, Alberta – TheNewswire – October 17, 2023 – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) announces an expansion…
Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM – An Important Commercial Milestone Achieved
TeloView Analyses Telomeres to Accurately Predict and Characterize Multiple MyelomaToronto, Ontario–(Newsfile Corp. – October 17, 2023) – Telo Genomics…
NervGen Pharma Appoints John Ruffolo to Board of Directors
Extensive experience in private equity, venture capital and advising high growth, innovative companiesBrings personal experience and knowledge of spinal…